Brief: Adicet Bio Q2 Basic EPS USD -1.99
05/08/2026 21:16
BRIEF-Adicet Bio Q2 Basic EPS USD -1.99 Aug 05 (Reuters) - Adicet Bio Q2 operating expenses USD 22.301 million.
- Q2 operating income USD -22.301 million
- Q2 net income USD -21.358 million
- Q2 EPS USD -1.99
Recent news on ADICET Bio
See all newsNASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Adicet Bio Announces Positive Safety And Efficacy Data From Prula-Cel (Formerly Adi-001) Study In Patients With Systemic Lupus Erythematosus With Or Without Lupus Nephritis
Brief: Adicet Bio Announces FDA Clearance Of Ind Application For Adi-212
Adicet Bio, Inc. Reports Results For The Quarter Ended June 30: Earnings Summary